FDA Raises Impurity Threshold to Address Losartan Shortage

Drug Industry Daily
A A
The FDA said it will allow drugmakers to sell losartan with higher levels of a potentially cancerous impurity over the next six months to prevent a shortage of the blood pressure drug.

To View This Article:

Login

Subscribe To Drug Industry Daily